SEB Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.15M Sell
170,752
-101,902
-37% -$2.82M 0.02% 480
2026
Q2
$9.24M Hold
272,654
– – 0.03% 352
2026
Q1
$8.73M Buy
+272,654
New +$8.88M 0.04% 339

Other funds holding NAMS

SEB Asset Management's NAMS Position: Q3 2026 in Review

SEB Asset Management reduced its NewAmsterdam Pharma (NAMS) stake by 37% in Q3 2026, selling an estimated $2.82M and leaving 170,752 shares worth $4.15M. The position accounts for 0.02% of the portfolio, ranked #480.

SEB Asset Management first reported a position in NAMS in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.24M in Q2 2026. 160 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

  • SEB Asset Management held 170,752 shares of NewAmsterdam Pharma worth $4.15M as of Q3 2026.
  • SEB Asset Management sold 101,902 NewAmsterdam Pharma shares in Q3 2026, an estimated $2.82M.
  • NewAmsterdam Pharma made up 0.02% of SEB Asset Management's portfolio in Q3 2026, its #480 holding.
  • SEB Asset Management first reported a position in NewAmsterdam Pharma in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's NewAmsterdam Pharma position peaked at $9.24M in Q2 2026.
  • 160 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.